The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Open accessAbstract
Reactive oxygen species (ROS) stimulate cell proliferation and induce genetic instability, and their increase in cancer cells is often viewed as an adverse event. Here, we show that such abnormal increases in ROS can be exploited to selectively kill cancer cells using beta-phenylethyl isothiocyanate (PEITC). Oncogenic transformation of ovarian epithelial cells with H-Ras(V12) or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC, which effectively disables the glutathione antioxidant system and causes severe ROS accumulation preferentially in the transformed cells due to their active ROS output. Excessive ROS causes oxidative mitochondrial damage, inactivation of redox-sensitive molecules, and massive cell death. In vivo, PEITC exhibits therapeutic activity and prolongs animal survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, this seems to be the case as compounds that raise ROS levels can effectively and selectively kill a variety of tumor cell lines 31, 74, 75.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,402
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,504
ROS stress in cancer cells and therapeutic implications
Pelicano, H., Carney, D. A., & Huang, P. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.004 · Cited by 2,031
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Self-citationMitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., & Goldschmidt-Clermont, P. J. (1997) · Science · doi:10.1126/science.275.5306.1649 · Cited by 1,588
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
Ren, R. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1567 · Cited by 1,078
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Superoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Li, F., Oldham, E. A., Keating, M. J., & Plunkett, W. K. (2000) · Nature · doi:10.1038/35030140 · Cited by 846
Flagged first, then by citations
Research works printed but not linked: 1
- Vereecque, 1999, A new murine aggressive leukemic model, Leuk. Res., 23, 415
Cited by
Sorted by citations
Items 401–500 of 999
Yang, F., Chen, W.-D., Deng, R., Li, D., Wu, K.-W., Feng, G., Li, H., & Zhu, X. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11235fp · Cited by 56
Ganguly, A., Chakraborty, P., Banerjee, K., & Choudhuri, S. K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.003 · Cited by 57
Luo, Y., Sun, X., Huang, L., Yan, J. C., Yu, B., & Tian, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07390 · Cited by 56
Wang, C.-A., Harrell, J. C., Iwanaga, R., Jedlicka, P., & Ford, H. L. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0462-2 · Cited by 59
Glutathione in metastases: From mechanisms to clinical applications
Estrela, J. M., Ortega, Á., Mena, S., Sirerol, J. A., & Obrador, E. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1136259 · Cited by 56
Oxidative Stress in the Newborn Period: Useful Biomarkers in the Clinical Setting
Millán, I., Piñeiro-Ramos, J. D., Lara‐Cantón, I., Llorca, A. P., Torres-Cuevas, I., & Vento, M. (2018) · Antioxidants · doi:10.3390/antiox7120193 · Cited by 55
Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression
Nakamae, I., Morimoto, T., Shima, H., Shionyu, M., Fujiki, H., Yoneda‐Kato, N., Yokoyama, T., Kanaya, S., Kakiuchi, K., Shirai, T., et al. (2019) · Molecules · doi:10.3390/molecules24224067 · Cited by 55
Gurunathan, S., Jeyaraj, M., Kang, M.-H., & Kim, J. (2020) · Antioxidants · doi:10.3390/antiox9040357 · Cited by 55
Apoptosis as a Mechanism of the Cancer Chemopreventive Activity of Glucosinolates: a Review
Arumugam, A., & Razis, A. F. A. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.6.1439 · Cited by 56
Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy
Akhtar, M. J., Alhadlaq, H. A., Kumar, S., Alrokayan, S., & Ahamed, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1570-1 · Cited by 55
Verrax, J., Dejeans, N., Sid, B., Glorieux, C., & Calderón, P. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.102 · Cited by 54
Cyclin C mediates stress-induced mitochondrial fission and apoptosis
Wang, K., Yan, R., Cooper, K. F., & Strich, R. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-08-1315 · Cited by 55
Khan, H. Y., Zubair, H., Ullah, M. F., Ahmad, A., & Hadi, S. M. (2011) · BioMetals · doi:10.1007/s10534-011-9475-9 · Cited by 53
Cao, S., Christiansen, R., & Peng, X. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300539 · Cited by 53
Samudio, I. J., Kurinna, S. M., Ruvolo, P. P., Korchin, B., Kantarjian, H. M., Beran, M., Dunner, K., Kondo, S., Andreeff, M., & Konopleva, M. Y. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0553 · Cited by 53
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
Naidu, S. D., Suzuki, T., Yamamoto, M. P., Fahey, J. W., & Dinkova‐Kostova, A. T. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700908 · Cited by 53
Raman, D., & Pervaiz, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101105 · Cited by 58
Pro- and antitumor effects of mitochondrial reactive oxygen species
Payen, V. L., Zampieri, L. X., Porporato, P. E., & Sonveaux, P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09789-2 · Cited by 56
Alwi, S. S. S., Cavell, B. E., Donlevy, A. M., & Packham, G. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0329-3 · Cited by 53
Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
Cockfield, J. A., & Schafer, Z. T. (2019) · Cancers · doi:10.3390/cancers11081208 · Cited by 58
Chakraborty, J. B., Mahato, S. K., Joshi, K., Shinde, V., Rakshit, S., Biswas, N., (Mukherjee), I. C., Mandal, L., Ganguly, D., Chowdhury, A. A., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02107.x · Cited by 52
Kasiappan, R., Jutooru, I., Karki, K., Hedrick, E., & Safe, S. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746339 · Cited by 52
Cysteine-based regulation of redox-sensitive Ras small GTPases
Messina, S., Simone, G. D., & Ascenzi, P. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101282 · Cited by 52
Rathore, K., Choudhary, S., Odoi, A., & Wang, H. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr244 · Cited by 51
CLIC4 is a tumor suppressor for cutaneous squamous cell cancer
Suh, K. S., Malik, M. Q., Shukla, A., Ryscavage, A. O., Wright, L. N., Jividen, K., Crutchley, J., Dumont, R. A., Fernández‐Salas, E., Webster, J. D., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs115 · Cited by 51
Cang, S., Ma, Y., Chiao, J.-W., & Liu, D. (2014) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-3-5 · Cited by 51
Luo, B., Cui, Q., Luo, H., Hu, Y., Huang, P., & Wen, S. (2016) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201600405 · Cited by 51
Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent
Yoo, D., Jung, E., Noh, J., Hyun, H., Seon, S., Hong, S., Kim, D., & Lee, D. (2019) · ACS Omega · doi:10.1021/acsomega.9b00140 · Cited by 51
Chen, P., Lin, K.-C., Lin, J.-P., Tang, N.-Y., Yang, J., Lu, K.-W., & Chung, J. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/718320 · Cited by 51
Javadov, S. A., Hunter, J. C., Barreto‐Torres, G., & Parodi‐Rullán, R. M. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000327943 · Cited by 49
Byun, S., Shin, S. H., Park, J., Lim, S., Lee, E., Lee, C., Sung, D.-E., Farrand, L., Lee, S. R., Kim, K. H., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501011 · Cited by 51
Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species
Nakayama, K., Murata, S., Ito, H., Iwasaki, K., Villareal, M. O., Zheng, Y., Matsui, H., Isoda, H., & Ohkohchi, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.6370 · Cited by 52
Ma, X., Hu, M., Wang, H., & Li, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.061 · Cited by 50
Modica-Napolitano, J. S., Bharath, L. P., Hanlon, A. J., & Hurley, L. D. (2019) · Biomolecules · doi:10.3390/biom9080298 · Cited by 52
Immunosuppressant Neurotoxicity in Rat Brain Models: Oxidative Stress and Cellular Metabolism
Klawitter, J., Gottschalk, S., Hainz, C., Leibfritz, D., Christians, U., & Serkova, N. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900351q · Cited by 49
Hou, Y., Yao, Y., Bao, Y., Song, Z., Yang, C., Gao, X.-L., Zhang, W.-J., Sun, L., Yu, C.-L., Huang, Y., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4941623 · Cited by 48
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia
Vangapandu, H. V., Havránek, O., Ayres, M., Kaipparettu, B. A., Balakrishnan, K., Wierda, W. G., Keating, M. J., Davis, R. E., Stellrecht, C. M., & Gandhi, V. V. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0026 · Cited by 49
Gurunathan, S., Jeyaraj, M., Kang, M.-H., & Kim, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186792 · Cited by 49
Reactive oxygen species delay control of lymphocytic choriomeningitis virus
Lang, P. A., Xu, H. C., Grusdat, M., McIlwain, D. R., Pandyra, A. A., Harris, I. S., Shaabani, N., Honke, N., Maney, S. K., Lang, E., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.167 · Cited by 51
Möhler, H., Pfirrmann, R. W., & Frei, K. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2566 · Cited by 49
Park, B., Cha, M., & Kim, I.-H. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-7 · Cited by 48
Zhou, K., Jiang, L., Shang, Z., Wang, J., Huang, L., & Zhou, J.-F. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.695359 · Cited by 48
Xiao, D., & Singh, S. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4451 · Cited by 48
Yu, M., Liu, T., Chen, Y.-C., Li, Y., & Li, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0779-2 · Cited by 51
Wu, H., Cheng, K., He, Y., Li, Z., Su, H., Zhang, X., Sun, Y., Shi, W., & Ge, D. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00468 · Cited by 48
Wang, J., Wang, Y., & Wong, C. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00659.x · Cited by 48
Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
Pignanelli, C., Ma, D., Noel, M., Ropat, J., Mansour, F., Curran, C., Pupulin, S., Larocque, K., Wu, J., Liang, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01230-4 · Cited by 47
Venè, R., Castellani, P., Delfino, L., Lucibello, M., Ciriolo, M. R., & Rubartelli, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3830 · Cited by 47
Tan, S. Y.-Y., Liu, Y., Chua, S. L., Vejborg, R. M., Jakobsen, T. H., Chew, S. C., Li, Y., Nielsen, T. E., Tolker‐Nielsen, T., Yang, L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02620-13 · Cited by 47
xCT Inhibition Increases Sensitivity to Vorinostat in a ROS-Dependent Manner
Miyamoto, Κ., Watanabe, M., Boku, S., Sukeno, M., Morita, M., Kondo, H., Sakaguchi, K., Taguchi, T., & Sakai, T. (2020) · Cancers · doi:10.3390/cancers12040827 · Cited by 50
Role of Phytochemicals in Perturbation of Redox Homeostasis in Cancer
Gaikwad, S. R., & Srivastava, S. (2021) · Antioxidants · doi:10.3390/antiox10010083 · Cited by 47
Yang, J., Lu, M., Lee, C.-L., Chen, G., Lin, Y.-Y., Chang, F., & Wu, Y. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.012 · Cited by 49
PLA2R1 kills cancer cells by inducing mitochondrial stress
Augert, A., Vindrieux, D., Girard, C. A. J., Calvé, B. L., Gras, B., Ferrand, M., Bouchet, B. P., Puisieux, A., de Launoit, Y., Simonnet, H., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.177 · Cited by 51
SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression
Alateyah, N., Gupta, I., Rusyniak, R. S., & Ouhtit, A. (2022) · Molecules · doi:10.3390/molecules27030811 · Cited by 48
Mechanisms of the Anticancer Effects of Isothiocyanates
Fofaria, N. M., Ranjan, A., Kim, S., & Srivastava, S. (2015) · The Enzymes · doi:10.1016/bs.enz.2015.06.001 · Cited by 46
Lee, C., Cho, H.-J., Jeong, Y., Shin, J.-M., Park, K., Park, Y.-Y., Bae, Y., Chung, I., Kim, M., Kim, C., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4292 · Cited by 46
Mitochondrial Permeability Transition as Target of Anticancer Drugs
Via, L. D., García‐Argáez, A. N., Martínez‐Vázquez, M., Grancara, S., Martinis, P., & Toninello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990033 · Cited by 48
Hauser, A. K., Anderson, K. W., & Hilt, J. Z. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0050 · Cited by 46
Sehrawat, A., Roy, R., Pore, S. K., Hahm, E., Samanta, S. K., Singh, K. B., Kim, S., Singh, K., & Singh, S. V. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.11.009 · Cited by 48
Mitsiogianni, M., Trafalis, D. T., Franco, R., Zoumpourlis, V., Pappa, A., & Panayiotidis, M. I. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02227-y · Cited by 48
Blanquer-Rosselló, M. D. M., Oliver, J., Valle, A., & Roca, P. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24627 · Cited by 49
Mitochondrial respiration supports autophagy to provide stress resistance during quiescence
Novais, S. M., Blecha, J., Naraine, R., Mikesova, J., Abaffy, P., Pecinová, A., Milošević, M., Bohuslavová, R., Procházka, J., Khan, S., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2038898 · Cited by 46
Park, Y.-H., Kim, S. U., Kwon, T.-H., Kim, J.-M., Song, I.-S., Hj, S., Lee, B.-K., Bang, D.-H., Lee, S., Lee, D.-S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.411 · Cited by 46
Ganguly, A., Basu, S., Chakraborty, P., Chatterjee, S., Sarkar, A., Chatterjee, M., & Choudhuri, S. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011253 · Cited by 45
Loganathan, S., Kandala, P. K., Gupta, P., & Srivastava, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043577 · Cited by 45
Bian, J., Li, X., Wang, N., Wu, X., You, Q., & Zhang, X. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.004 · Cited by 45
Adenanthin targets peroxiredoxin I/II to kill hepatocellular carcinoma cells
Hou, J.-K., Huang, Y., He, W., Yan, Z.-W., Fan, L., Liu, M.-H., Xiao, W.-L., Sun, H., & Chen, G.-Q. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.345 · Cited by 46
A pan-cancer study of selenoprotein genes as promising targets for cancer therapy
Wu, W., Li, D., Feng, X., Zhao, F., Li, C., Zheng, S., & Lyu, J. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00930-1 · Cited by 44
Roh, M., van der Meer, R., & Abdulkadir, S. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22793 · Cited by 45
Oxidative Stress by Targeted Agents Promotes Cytotoxicity in Hematologic Malignancies
Chandra, J. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2302 · Cited by 44
Ju, D., Yamaguchi, F., Zhan, G., Higuchi, T., Asakura, T., Morita, A., Orimo, H., & Hu, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-4931-3 · Cited by 44
Kwan, S.-Y., Cheng, X., Tsang, Y. T. M., Choi, J.-S., Kwan, S., Izaguirre, D. I., Kwan, H. S., Gershenson, D. M., & Wong, K. (2016) · Oncotarget · doi:10.18632/oncotarget.10921 · Cited by 43
Al-Bakheit, A. A., Τράκα, Μ., Saha, S., Mithen, R. F., & Melchini, A. (2016) · The Prostate · doi:10.1002/pros.23222 · Cited by 44
Shamim, U., Hanif, S., Ullah, M. F., Azmi, A. S., Bhat, S. H., & Hadi, S. M. (2008) · Free Radical Research · doi:10.1080/10715760802302251 · Cited by 43
Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells
Gao, Y. H., Howard, A., Ban, K., & Chandra, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804801200 · Cited by 43
Lee, D. H., Jung, Y. J., Koh, D., Lim, Y., Lee, Y. H., & Shin, S. Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.017 · Cited by 43
Cetinbas, N. M., Sudderth, J., Harris, R. C., Cebeci, A., Negri, G. L., Yilmaz, Ö. H., DeBerardinis, R. J., & Sorensen, P. H. B. (2016) · Scientific Reports · doi:10.1038/srep32606 · Cited by 45
Vidimar, V., Gius, D. R., Chakravarti, D., Bulun, S. E., Wei, J., & Kim, J. J. (2016) · Science Advances · doi:10.1126/sciadv.1601132 · Cited by 45
Development of Isoselenocyanate Compounds’ Syntheses and Biological Applications
Frieben, E. E., Amin, S., & Sharma, A. K. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01698 · Cited by 43
Bekhet, O. H., & Eid, M. E. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-629 · Cited by 45
Metformin-Loaded BSA Nanoparticles in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug
Jose, P., Sundar, K., Anjali, C., & Ravindran, A. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0242-8 · Cited by 43
S-Nitrosylation Regulates Nuclear Translocation of Chloride Intracellular Channel Protein CLIC4
Malik, M. Q., Shukla, A., Amin, P. P., Niedelman, W., Lee, J., Jividen, K., Phang, J. M., Ding, J., Suh, K. S., Curmi, P. M. G., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091611 · Cited by 43
Halasi, M., Pandit, B., Wang, M., Nogueira, V., Hay, N., & Gartel, A. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.03.012 · Cited by 43
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
Bourouh, M., & Marignani, P. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.881297 · Cited by 48
Briehl, M. M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.002 · Cited by 41
CDDO-Imidazolide Induces DNA Damage, G2/M Arrest and Apoptosis in BRCA1-Mutated Breast Cancer Cells
Kim, E., Deng, C., Sporn, M. B., & Liby, K. T. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0153 · Cited by 42
Kozak, J., Jonak, K. E., & Maciejewski, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110037 · Cited by 42
Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy
Mani, S., Swargiary, G., & Ralph, S. J. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.11.002 · Cited by 43
The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis
Zhang, S., Hu, R., Geng, Y., Chen, K., Wang, L., & Imam, M. U. (2021) · Foods · doi:10.3390/foods10122952 · Cited by 42
Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma
Lang, M., Wang, X., Wang, H., Dong, J., Lan, C., Hao, J., Huang, C., Li, X., Yu, M., Yang, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.016 · Cited by 42
Ma, D., Pignanelli, C., Tarade, D., Gilbert, T., Noel, M., Mansour, F., Adams, S., Dowhayko, A., Stokes, K., Vshyvenko, S., et al. (2017) · Scientific Reports · doi:10.1038/srep42957 · Cited by 42
Zhu, P., Wang, M., Chen, Z.-L., & Yang, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761107 · Cited by 45
Ames, J. B., Lurie, J. D., Tomek, I. M., Zhou, W., & Koval, K. J. (2010) · PubMed · Cited by 41
Liu, Y., Chang, Y., Yang, C., Sang, Z., Yang, T., Ang, W., Ye, W., Wei, Y., Gong, C., & Luo, Y. (2014) · Nanoscale · doi:10.1039/c3nr06599e · Cited by 41
Exploiting mitochondrial apoptosis for the treatment of cancer
Fulda, S. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.001 · Cited by 42
Ablation of TAK1 Upregulates Reactive Oxygen Species and Selectively Kills Tumor Cells
Omori, E., Matsumoto, K., Zhu, S., Smart, R. C., & Ninomiya‐Tsuji, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1227 · Cited by 41
Bacchetti, T., Campagna, R., Sartini, D., Cecati, M., Morresi, C., Bellachioma, L., Martinelli, E., Rocchetti, G., Lucini, L., Ferretti, G., et al. (2022) · Molecules · doi:10.3390/molecules27196488 · Cited by 40
Chen, H.-M., Chang, F., Hsieh, Y.-C., Cheng, Y.-J., Hsieh, K., Tsai, L.-M., Lin, A., Wu, Y., & Yuan, S. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.015 · Cited by 40
Lu, C., Huang, B., Liao, P., & Yen, G. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400051 · Cited by 39
Lebedeva, I. V., Su, Z.-Z., Vozhilla, N., Chatman, L., Sarkar, D., Dent, P., Athar, M., & Fisher, P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0072 · Cited by 40
Metadata
- Authors
- Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., & Huang, P.
- Affiliations
- Thammasat University (TH)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Huang, Peng
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 10
- Issue
- 3
- Pages
- 241-252
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1993238109
- Cited by
- 1,080
- References
- 43
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 36 · 2023: 40 · 2022: 59 · 2021: 54 · 2020: 50 · 2019: 58 · 2018: 58 · 2017: 68 · 2016: 83 · 2015: 59 · 2014: 83 · 2013: 65 · 2012: 73
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA-16 672)
- National Cancer Institute (CA-16672, CA085563, R01CA109041, CA109041, R01CA085563, R01CA100428, CA100428, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- reactive oxygen species, selective cytotoxicity, oncogenic transformation, H-Ras V12, BCR-ABL, glutathione antioxidant system, oxidative stress, ovarian epithelial cells, hematopoietic cells, cancer cell death, cancer therapy
- MeSH terms
- Animals, Antioxidants, Cell Line, Cell Transformation, Neoplastic, Glutathione, Humans, Neoplasms, Oncogene Protein p21(ras), Survival Rate, Fusion Proteins, bcr-abl, Cell Death, Reactive Oxygen Species, Isothiocyanates, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
